Rüveyda Ayasun

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis”.

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Nature Communications(2022)10.1038/s41467-022-30615-x

N/A

5.0DataRank · unranked

123 citations

Alice Wang, Daniel Kim, Bryan D. Young, Katelyn Singh, Michael J. Murphy +15 more

Treatment of sarcoidosis with cutaneous involvement with tofacitinib

medRxiv(2021)10.1101/2021.07.01.21259700

N/A

0DataRank · unranked

2 citations

Alice Wang, Bryan D. Young, Rüveyda Ayasun, Changwan Ryu, Meaghan K. McGeary +8 more

A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0196

N/A

0DataRank · unranked

4 citations

Jeffrey A. Schneider, Susan Ha, Rachel Ruoff, Luiza Doro Pereira, Joseph Puccini +13 more

Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.24.671070

N/A

0DataRank · unranked

0 citations

Maayan Pour, Jaylen M Powell, Yuan Hao, Dimitris Nasias, Yi Jer Tan +27 more